Heron Therapeutics Inc

NASDAQ:HRTX   3:59:52 PM EDT
4.87
+0.16 (+3.51%)
Layoffs, Earnings Announcements

Heron Therapeutics Inc Says Employees Impacted By Reduction In Force Will Exit Company In Third And Fourth Quarters Of 2022

Published: 06/30/2022 13:01 GMT
Heron Therapeutics Inc (HRTX) - Heron Therapeutics Inc - Employees Impacted by Reduction in Force Will Exit Company in Third and Fourth Quarters of 2022.
Heron Therapeutics Inc - Will Provide Employees With One-time Severance Payments Upon Termination, Continued Benefits for a Specific Period of Time.
Heron Therapeutics Inc - Expects to Incur Total Expenses of $6.3 Million, $5.9 Million of Which is Primarily for Severance and Related Costs.
Heron Therapeutics Inc - Anticipates Recognizing $4.3 Million of Total Expenses in Q2 of 2022, $1.3 Million of Total Expenses in Q3 of 2022.
Heron Therapeutics Inc - Expects Cash Payments Due to Terminated Employees Will Be Substantially Completed in Q1.
Further Company Coverage: Hrtxo
Revenue is expected to be $27.84 Million
Adjusted EPS is expected to be -$0.38

Next Quarter Revenue Guidance is expected to be $30.96 Million
Next Quarter EPS Guidance is expected to be -$0.27

More details on our Analysts Page.